AlgiMatrix™ Based 3D Cell Culture System as an In-Vitro Tumor Model for Anticancer Studies

Background Three-dimensional (3D) in-vitro cultures are recognized for recapitulating the physiological microenvironment and exhibiting high concordance with in-vivo conditions. Taking the advantages of 3D culture, we have developed the in-vitro tumor model for anticancer drug screening. Methods Cancer cells grown in 6 and 96 well AlgiMatrix™ scaffolds resulted in the formation of multicellular spheroids in the size range of 100–300 µm. Spheroids were grown in two weeks in cultures without compromising the growth characteristics. Different marketed anticancer drugs were screened by incubating them for 24 h at 7, 9 and 11 days in 3D cultures and cytotoxicity was measured by AlamarBlue® assay. Effectiveness of anticancer drug treatments were measured based on spheroid number and size distribution. Evaluation of apoptotic and anti-apoptotic markers was done by immunohistochemistry and RT-PCR. The 3D results were compared with the conventional 2D monolayer cultures. Cellular uptake studies for drug (Doxorubicin) and nanoparticle (NLC) were done using spheroids. Results IC50 values for anticancer drugs were significantly higher in AlgiMatrix™ systems compared to 2D culture models. The cleaved caspase-3 expression was significantly decreased (2.09 and 2.47 folds respectively for 5-Fluorouracil and Camptothecin) in H460 spheroid cultures compared to 2D culture system. The cytotoxicity, spheroid size distribution, immunohistochemistry, RT-PCR and nanoparticle penetration data suggested that in vitro tumor models show higher resistance to anticancer drugs and supporting the fact that 3D culture is a better model for the cytotoxic evaluation of anticancer drugs in vitro. Conclusion The results from our studies are useful to develop a high throughput in vitro tumor model to study the effect of various anticancer agents and various molecular pathways affected by the anticancer drugs and formulations.

[1]  R. Jain,et al.  Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors , 2011, Proceedings of the National Academy of Sciences.

[2]  A. Letai,et al.  The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance , 2011, Cell Death and Disease.

[3]  B. Ang,et al.  Cancer stem cell: target for anti‐cancer therapy , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  D. Fennell,et al.  Bcl-2 family proteins contribute to apoptotic resistance in lung cancer multicellular spheroids. , 2009, American journal of respiratory cell and molecular biology.

[5]  Genee Y. Lee,et al.  Three-dimensional culture models of normal and malignant breast epithelial cells , 2007, Nature Methods.

[6]  Joseph W Freeman,et al.  3D in vitro bioengineered tumors based on collagen I hydrogels. , 2011, Biomaterials.

[7]  P. Schultz,et al.  Combination Therapy Targeting Both Tumor-Initiating and Differentiated Cell Populations in Prostate Carcinoma , 2010, Clinical Cancer Research.

[8]  Jin Han,et al.  The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. , 2012, Biomaterials.

[9]  A. Minchinton,et al.  Direct Assessment of Drug Penetration into Tissue Using a Novel Application of Three-Dimensional Cell Culture , 2004, Cancer Research.

[10]  Daniel V LaBarbera,et al.  The multicellular tumor spheroid model for high-throughput cancer drug discovery , 2012, Expert opinion on drug discovery.

[11]  Maria Bokhari,et al.  Culture of HepG2 liver cells on three dimensional polystyrene scaffolds enhances cell structure and function during toxicological challenge , 2007, Journal of anatomy.

[12]  Alok R Ray,et al.  Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen. , 2005, Biomaterials.

[13]  Thomas Streichert,et al.  Genome-Wide Gene Expression Analysis in Cancer Cells Reveals 3D Growth to Affect ECM and Processes Associated with Cell Adhesion but Not DNA Repair , 2012, PloS one.

[14]  Shufang Zhang,et al.  Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies. , 2010, Biomaterials.

[15]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[16]  Tobias Schmelzle,et al.  Engineering tumors with 3D scaffolds , 2007, Nature Methods.

[17]  D. Messadi,et al.  A novel 3‐dimensional culture system as an in vitro model for studying oral cancer cell invasion , 2005, International journal of experimental pathology.

[18]  Christopher Haslett,et al.  Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo , 1999, Nature Medicine.

[19]  S. Sahoo,et al.  3-D tumor model for in vitro evaluation of anticancer drugs. , 2008, Molecular pharmaceutics.

[20]  R. Patlolla,et al.  Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[21]  K. Nagashima,et al.  The Development and Characterization of a Human Mesothelioma In Vitro 3D Model to Investigate Immunotoxin Therapy , 2011, PloS one.

[22]  Chandana Mohanty,et al.  A novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs , 2012, Molecular vision.

[23]  Glenn D Prestwich,et al.  Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery. , 2008, Accounts of chemical research.

[24]  C. Addison,et al.  β1 integrin , 2012, Cell adhesion & migration.

[25]  Kenneth M. Yamada,et al.  Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.

[26]  T. Matsushita,et al.  Enhancement of drug efflux activity via MDR1 protein by spheroid culture of human hepatic cancer cells. , 2011, Journal of bioscience and bioengineering.

[27]  Benjamin M. Wu,et al.  The role of the 3D environment in hypoxia-induced drug and apoptosis resistance. , 2011, Anticancer research.

[28]  A. Perets,et al.  Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. , 2003, Journal of biomedical materials research. Part A.

[29]  D. Simeone,et al.  Cancer stem cells: a new theory regarding a timeless disease. , 2009, Chemical reviews.

[30]  Alastair H Kyle,et al.  Limited Tissue Penetration of Taxanes: A Mechanism for Resistance in Solid Tumors , 2007, Clinical Cancer Research.

[31]  Dietmar W. Hutmacher,et al.  Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. , 2010, Biomaterials.

[32]  The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer , 2012, Journal of Translational Medicine.

[33]  L. Griffith,et al.  Capturing complex 3D tissue physiology in vitro , 2006, Nature Reviews Molecular Cell Biology.

[34]  Kenneth M. Yamada,et al.  Modeling Tissue Morphogenesis and Cancer in 3D , 2007, Cell.

[35]  JONG BIN Kim,et al.  Three-dimensional tissue culture models in cancer biology. , 2005, Seminars in cancer biology.

[36]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[37]  David J Mooney,et al.  Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement , 2009, Proceedings of the National Academy of Sciences.

[38]  Glenn D Prestwich,et al.  Simplifying the extracellular matrix for 3‐D cell culture and tissue engineering: A pragmatic approach , 2007, Journal of cellular biochemistry.

[39]  F. Pampaloni,et al.  The third dimension bridges the gap between cell culture and live tissue , 2007, Nature Reviews Molecular Cell Biology.